Exagen Inc. provided revenue guidance for the third quarter of 2023. Revenue guidance for the third quarter of 2023 in the range of $10 million to $10.5 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.465 USD | +3.90% | +5.00% | -26.13% |
26/04 | Exagen Inc. Announces Changes in Board of Directors | CI |
18/03 | Exagen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.13% | 24.47M | |
+20.59% | 84.31B | |
-29.08% | 69.9B | |
+9.65% | 29.06B | |
-8.86% | 17.38B | |
+2.14% | 17.01B | |
+0.25% | 15.35B | |
+6.61% | 12.91B | |
+68.10% | 12.47B | |
+6.43% | 12.26B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Exagen Inc. Provides Revenue Guidance for the Third Quarter of 2023